Literature DB >> 20035531

Randomized clinical trial of symptom control after stapled anopexy or diathermy excision for haemorrhoid prolapse.

P-O Nyström1, N Qvist, D Raahave, I Lindsey, N Mortensen.   

Abstract

BACKGROUND: : This multicentre randomized clinical trial studied how symptoms improved after either stapled anopexy or diathermy excision of haemorrhoids.
METHODS: : The study involved 18 hospitals in Sweden, Denmark and the UK. Some 207 patients were randomized to either anopexy or Milligan-Morgan haemorrhoidectomy, of whom 90 in each group were operated on. Patients reported symptoms before surgery and after 1 year. Daily postoperative pain scores were recorded in a patient diary. Surgeons evaluated the anal anatomy before surgery and after 1 year.
RESULTS: : Correction of prolapse in the anopexy and haemorrhoidectomy groups was similar at 1 year (88 and 90 per cent respectively; P = 0.80). Freedom from symptoms was obtained in 44 and 69 per cent respectively (P = 0.002). Stapled anopexy was associated with less postoperative pain, which resolved more quickly (P = 0.004). Significant improvements were noted in anal continence and well-being 1 year after both operations (P < 0.001). Excessive pain was the most common complication after diathermy excision and disturbed bowel function after stapled anopexy.
CONCLUSION: : Haemorrhoidal prolapse was corrected equally by either operation. Diathermy haemorrhoidectomy gave better symptom relief but was more painful. Neither operation provided complete cure but well-being was greatly improved. REGISTRATION NUMBER: ISRCTN68315343 (http://www.controlled-trials.com). Copyright (c) 2009 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2010        PMID: 20035531     DOI: 10.1002/bjs.6804

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  28 in total

Review 1.  Stapled haemorrhoidopexy: is it time to move on?

Authors:  E H Aly
Journal:  Ann R Coll Surg Engl       Date:  2015-08-14       Impact factor: 1.891

2.  Gabapentin significantly decreases posthemorrhoidectomy pain: a prospective study.

Authors:  Vitaliy Poylin; Jeanne Quinn; Kristin Messer; Deborah Nagle
Journal:  Int J Colorectal Dis       Date:  2014-10-01       Impact factor: 2.571

Review 3.  Documented complications of staple hemorrhoidopexy: a systematic review.

Authors:  Liesel J Porrett; Jemma K Porrett; Yik-Hong Ho
Journal:  Int Surg       Date:  2015-01

4.  Hubble trial: time to stick to basics for treatment of haemorrhoids?

Authors:  S R Brown
Journal:  Tech Coloproctol       Date:  2016-10-03       Impact factor: 3.781

Review 5.  Review of Hemorrhoid Disease: Presentation and Management.

Authors:  Zhifei Sun; John Migaly
Journal:  Clin Colon Rectal Surg       Date:  2016-03

6.  Stapled hemorrhoidopexy - Initial experience from a general surgery center.

Authors:  S S Jaiswal; Darpan Gupta; Saket Davera
Journal:  Med J Armed Forces India       Date:  2012-11-30

Review 7.  Clinical Outcome Following Hemorrhoid Surgery: a Narrative Review.

Authors:  Marcello Picchio; Ettore Greco; Annalisa Di Filippo; Giuseppe Marino; Francesco Stipa; Erasmo Spaziani
Journal:  Indian J Surg       Date:  2014-05-10       Impact factor: 0.656

8.  Long-term results after stapled hemorrhoidopexy: a survey study with mean follow-up of 12 years.

Authors:  A Sturiale; B Fabiani; C Menconi; D Cafaro; F Fusco; G Bellio; M Schiano di Visconte; G Naldini
Journal:  Tech Coloproctol       Date:  2018-10-04       Impact factor: 3.781

9.  Transanal haemorrhoidal dearterialisation with mucopexy versus stapler haemorrhoidopexy: a randomised trial with long-term follow-up.

Authors:  P Lucarelli; M Picchio; M Caporossi; F De Angelis; A Di Filippo; F Stipa; E Spaziani
Journal:  Ann R Coll Surg Engl       Date:  2013-05       Impact factor: 1.891

Review 10.  Comments to 'Rubber band ligation versus excisional haemorrhoidectomy for haemorrhoids'.

Authors:  S R Brown; A Watson
Journal:  Tech Coloproctol       Date:  2016-03-29       Impact factor: 3.781

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.